Bill
HR 1806
The Triple-Negative Breast Cancer Research and Education Act boosts funding for TNBC research and education, improving outcomes for patients and training for healthcare providers.
The Triple-Negative Breast Cancer Research and Education Act of 2025 aims to enhance research, education, and awareness surrounding triple-negative breast cancer (TNBC), a particularly aggressive form of breast cancer that lacks three common receptors known to fuel most breast cancer growth. The bill seeks to improve outcomes for patients by increasing funding for research and educational initiatives focused on TNBC.
The bill includes several significant provisions designed to address the challenges posed by TNBC:
Increased Research Funding: The legislation proposes allocating federal funds specifically for research into the causes, prevention, and treatment of triple-negative breast cancer.
Educational Programs: It mandates the development of educational programs aimed at healthcare providers and the general public to raise awareness about TNBC, its risks, and available treatment options.
Collaboration with Organizations: The bill encourages partnerships with non-profit organizations, academic institutions, and healthcare providers to facilitate research and disseminate information effectively.
Data Collection and Analysis: It calls for improved data collection on TNBC cases to better understand its prevalence and impact, which will inform future research and treatment strategies.
The following groups would be directly impacted by the provisions of this bill:
Patients: Individuals diagnosed with triple-negative breast cancer would benefit from enhanced research leading to better treatment options and outcomes.
Healthcare Providers: Medical professionals would receive updated training and resources to improve their understanding and management of TNBC.
Researchers: Scientists and researchers focused on cancer studies would gain access to increased funding and resources to advance their work on TNBC.
Public Health Organizations: Non-profit organizations dedicated to cancer awareness and education would have opportunities to collaborate on initiatives aimed at improving public knowledge about TNBC.
Introduced Date: The bill was introduced in the House on March 3, 2025.
Committee Referral: Following its introduction, HR 1806 was referred to the House Committee on Energy and Commerce for further consideration.
The bill is sponsored by a diverse group of legislators, including:
These sponsors represent a bipartisan effort to address the critical issue of triple-negative breast cancer through legislative action.
The Triple-Negative Breast Cancer Research and Education Act of 2025 represents a proactive approach to tackling the challenges associated with one of the most aggressive forms of breast cancer. By focusing on research funding and education, the bill aims to improve patient outcomes and raise awareness about TNBC, ultimately benefiting patients, healthcare providers, and researchers alike.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.
